| |
| |
|
| Insider
Information: |
Weiss Michael S |
| Relationship: |
Director |
| City: |
Berkeley Heights |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
16,329,233 |
|
|
Indirect Shares
|
14,546,388 |
|
|
| Direct
Value |
$215,927,662 |
|
|
|
Indirect Value
|
$238,086,734 |
|
|
| Total
Shares |
30,875,621 |
|
|
| Total
Value |
$454,014,396 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
2
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -2.8%
|
-135.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
10% Owner |
2010-05-10 |
1,320,418 |
2003-11-21 |
0 |
Premium* |
|
|
Genta Inc De |
GNTAQ |
Director |
2005-08-05 |
537,238 |
2004-07-14 |
0 |
Premium* |
|
|
XTL Biopharmaceuticals Ltd |
XTLBY |
Director |
2008-08-22 |
25,000 |
|
0 |
Premium* |
|
|
TG Therapeutics Inc |
TGTX |
CEO |
2024-01-06 |
13,074,929 |
2020-06-22 |
14,434,214 |
Premium* |
|
|
Fortress Biotech, Inc. |
FBIO |
See Remarks, Director,... |
2024-01-01 |
1,346,985 |
2013-12-19 |
0 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
Director |
2017-06-15 |
0 |
2024-05-14 |
112,174 |
Premium* |
|
|
Avenue Therapeutics, Inc. |
ATXI |
Director |
2018-08-07 |
24,663 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
126 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
• • – |
2003-06-04 |
4 |
B |
$1.75 |
$8,750 |
D/D |
5,000 |
15,000 |
2.81 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
• • – |
2003-11-21 |
4 |
B |
$4.22 |
$21,261 |
D/D |
5,000 |
10,000 |
2.81 |
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2003-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,600 |
591,838 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2004-03-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2004-03-17 |
4/A |
GD |
$0.00 |
$0 |
D/D |
6,000 |
585,838 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2004-06-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,500 |
579,838 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
• – – |
2004-06-15 |
4 |
B |
$10.92 |
$54,600 |
D/D |
5,000 |
647,385 |
2.74 |
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2004-06-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,750 |
576,088 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2004-06-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,000 |
565,088 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2004-07-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
564,588 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2004-10-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
564,088 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2004-11-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,600 |
560,488 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2005-03-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,800 |
555,688 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2005-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
550 |
555,138 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2005-06-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,500 |
537,638 |
|
- |
|
| GNTAQ |
Genta Inc De |
Director |
– • – |
2005-08-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
537,238 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-02-21 |
4 |
OE |
$1.30 |
$52,000 |
D/D |
40,000 |
55,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-02-21 |
4 |
AS |
$16.31 |
$665,934 |
D/D |
(40,000) |
15,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-03-21 |
4 |
AS |
$18.25 |
$1,462,376 |
D/D |
(80,000) |
15,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-03-21 |
4 |
OE |
$1.30 |
$104,000 |
D/D |
80,000 |
95,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chariman and CEO |
• • – |
2006-04-18 |
4 |
OE |
$1.30 |
$52,000 |
D/D |
40,000 |
55,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chariman and CEO |
• • – |
2006-04-18 |
4 |
AS |
$17.03 |
$683,472 |
D/D |
(40,000) |
15,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-05-16 |
4 |
OE |
$1.30 |
$52,000 |
D/D |
40,000 |
55,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-05-16 |
4 |
AS |
$15.45 |
$390,087 |
D/D |
(25,000) |
30,000 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chairman and CEO |
• • – |
2006-05-17 |
4 |
AS |
$14.72 |
$222,846 |
D/D |
(15,000) |
15,000 |
|
- |
|
126 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
